Next week, the National Pharmaceutical Pricing Authority (NPPA) of India will delve into the pricing caps for knee implants, a move that previously helped slash costs for patients.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/OrTcBNL
via IFTTT
No comments:
Post a Comment